Clinical Trials Browser

Interventional × Erlotinib Hydrochloride × Other neoplasm × Clear all

NCT00314262 2014-10-24

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Phase 1/2 Completed

17 enrolled 7 charts

Precancerous Conditions

NCT00566800 2013-09-17

Erlotinib in Treating Patients With Barrett Esophagus

Phase 1 Unknown

GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions